Literature DB >> 23891219

Increasing prevalence of blaOXA-23-carrying Acinetobacter baumannii and the emergence of blaOXA-182-carrying Acinetobacter nosocomialis in Korea.

Yangsoon Lee1, Young-Ree Kim, Jayoung Kim, Yeon-Joon Park, Wonkeun Song, Jong-Hee Shin, Young Uh, Kyutaeg Lee, Seong Hee Lee, Ji Hyun Cho, Dongeun Yong, Seok Hoon Jeong, Kyungwon Lee, Yunsop Chong.   

Abstract

Carbapenem-resistant Acinetobacter spp. have been increasingly reported worldwide with the production of OXA-type carbapenemases as the main mechanism of carbapenem resistance. The prevalent bla(OXA) genes are known to vary significantly depending on time and place of isolation. We investigated the prevalence of bla(OXA) genes by PCR in Acinetobacter spp. isolated in Korea. Among a total of 336 isolates collected from Hospital A from 2002 to 2011, the overall proportion of bla(OXA)-23-like, ISAba1-associated bla(OXA-51)-like, and bla(OXA-182) genes were 44.0%, 49.7%, and 5.1%, respectively. The bla(OXA-58)-like gene was detected in only 1 isolate. A drastic increase in Acinetobacter isolates with bla(OXA-23)-like genes and a decrease in isolates harboring ISAba1-associated bla(OXA-51)-like genes have been observed since the mid-2000s. The bla(OXA-23)-like genes were detected in all carbapenem-nonsusceptible isolates collected in 2011 from 9 hospitals. The OXA-182, which belongs to the fifth group of OXA-type carbapenemase, was detected in Acinetobacter baumannii isolates recovered as early as 2002. It is worrisome results that bla(OXA-182)-carrying Acinetobacter nosocomialis has emerged and caused outbreaks of infection.
© 2013.

Entities:  

Keywords:  Acinetobacter baumannii; Acinetobacter nosocomialis; bla(OXA-182); bla(OXA-23)

Mesh:

Substances:

Year:  2013        PMID: 23891219     DOI: 10.1016/j.diagmicrobio.2013.06.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

1.  Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China.

Authors:  Nian-Zhi Ning; Xiong Liu; Chun-Mei Bao; Su-Ming Chen; En-Bo Cui; Ju-Ling Zhang; Jie Huang; Fang-Hong Chen; Tao Li; Fen Qu; Hui Wang
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

2.  Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015.

Authors:  Dokyun Kim; Ji Young Ahn; Chae Hoon Lee; Sook Jin Jang; Hyukmin Lee; Dongeun Yong; Seok Hoon Jeong; Kyungwon Lee
Journal:  Ann Lab Med       Date:  2017-05       Impact factor: 3.464

Review 3.  Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea.

Authors:  Young Ah Kim; Yoon Soo Park
Journal:  Korean J Intern Med       Date:  2018-02-27       Impact factor: 2.884

4.  Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital.

Authors:  Yili Chen; Lu Ai; Penghao Guo; Han Huang; Zhongwen Wu; Xiaoling Liang; Kang Liao
Journal:  BMC Infect Dis       Date:  2018-12-04       Impact factor: 3.090

5.  Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii.

Authors:  Mohammad Hamidian; Steven J Nigro
Journal:  Microb Genom       Date:  2019-10

6.  Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.

Authors:  Yinyue Li; Bo Wang; Feng Lu; Juhee Ahn; Wenwen Zhang; Liangliang Cai; Jiahui Xu; Yi Yin; Qingchao Cao; Zhenyu Ren; Xinlong He
Journal:  Microbiol Spectr       Date:  2022-02-23

7.  Prevalence of Genes of OXA-23 Carbapenemase and AdeABC Efflux Pump Associated with Multidrug Resistance of Acinetobacter baumannii Isolates in the ICU of a Comprehensive Hospital of Northwestern China.

Authors:  Wei Jia; Caiyun Li; Haiyun Zhang; Gang Li; Xiaoming Liu; Jun Wei
Journal:  Int J Environ Res Public Health       Date:  2015-08-21       Impact factor: 3.390

8.  Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.

Authors:  Daniel De Vos; Jean-Paul Pirnay; Florence Bilocq; Serge Jennes; Gilbert Verbeken; Thomas Rose; Elkana Keersebilck; Petra Bosmans; Thierry Pieters; Mony Hing; Walter Heuninckx; Frank De Pauw; Patrick Soentjens; Maia Merabishvili; Pieter Deschaght; Mario Vaneechoutte; Pierre Bogaerts; Youri Glupczynski; Bruno Pot; Tanny J van der Reijden; Lenie Dijkshoorn
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

9.  In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.

Authors:  Nam Su Ku; Su-Hyung Lee; Young- Soun Lim; Heun Choi; Jin Young Ahn; Su Jin Jeong; Sung Jae Shin; Jun Yong Choi; Young Hwa Choi; Joon-Sup Yeom; Dongeun Yong; Young Goo Song; June Myung Kim
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.